NSC |
Compound |
Enrichment |
Correlation |
NSC 93301 |
Null |
0.0260391472224207 |
0.022550174 |
NSC 102225 |
Null |
0.0267520285931239 |
0.29998274 |
NSC 113423 |
NSC 113423 |
0.0267520285931239 |
0.030567586 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0267520285931239 |
0.049042986 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0267520285931239 |
0.083812025 |
NSC 134459 |
Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) |
0.0267520285931239 |
0.21179055 |
NSC 13484 |
Null |
0.0267520285931239 |
0.33171309 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0267520285931239 |
0.24595014 |
NSC 175493 |
Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- |
0.0267520285931239 |
0.12900356 |
NSC 21683 |
Null |
0.0267520285931239 |
0.34125266 |